09th BIO.NRW Business Angel Congress

09th BIO.NRW Business Angel Congress

09th BIO.NRW Business Angel CongressMarch 09th, 2020 Learn more Priavoid will participate at the 09th BIO.NRW Business Angel Congress. News & Events: 09th BIO.NRW Business Angel Congress3. März 2020 BIO.NRW MEDICA-FORUM3. Dezember 2019 DGN Kongress 20192. Oktober...
BIO.NRW MEDICA-FORUM

BIO.NRW MEDICA-FORUM

BIO.NRW MEDICA-ForumNovember 18th, 2019 Learn more As part of the BIO.NRW MEDICA-Forum on Monday, 18.11.2019, Prof. Dieter Willbold presented Priavoid’s latest research data during his talk “Do we need anti-prionic compounds to treat Alzheimer’s disease?” News...
DGN Kongress 2019

DGN Kongress 2019

DGN Kongress - StuttgartSeptember 26th, 2019 Learn more Prof. Dieter Willbold participated at the DGN Kongress in Stuttgart.He gave a talk on the 26th September at 09.10 am.Content: Targeting Alzheimer´s disease with the first anti-prionic compound: PRI-002 proved...
AAIC 2019

AAIC 2019

AAIC - Los AngelesJuly 14th – 18th, 2019 Learn more Priavoid will participate at the AAIC 2019 in Los Angeles. News & Events: BIO.NRW MEDICA-FORUM3. Dezember 2019 DGN Kongress 20192. Oktober 2019 Seed Investment6. Mai 2019 CEOs of Priavoid3. Mai 2019 AD/PD...
Keystone Symposium

Keystone Symposium

Keystone SymposiumJune 18th, 2019 – Keystone, CO, USA Learn more Dieter Willbold will present PRI-002 at the Keystone Symposium “Neurodegenerative Diseases: New Insights and Therapeutic Opportunities (Z2) in Keystone, CO, USA. News & Events: BIO.NRW...